Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Passage Bio, Inc. (PASG) had Stock-Based Compensation of $3.00M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-45.52M |
|
-- |
|
-- |
|
$49.30M |
|
$-49.30M |
|
$3.77M |
|
$-45.52M |
|
$-45.52M |
|
$-45.52M |
|
$-45.52M |
|
$-45.52M |
|
$-45.52M |
|
$-49.30M |
|
$-48.44M |
|
3.17M |
|
3.17M |
|
$-14.35 |
|
$-14.35 |
|
| Balance Sheet Financials | |
$47.76M |
|
$4.11M |
|
$14.52M |
|
$62.28M |
|
$23.08M |
|
-- |
|
$20.44M |
|
$43.53M |
|
$18.75M |
|
$18.75M |
|
$18.75M |
|
3.18M |
|
| Cash Flow Statement Financials | |
$-31.51M |
|
$40.22M |
|
$0.02M |
|
$37.57M |
|
$46.30M |
|
$8.73M |
|
|
Stock-Based Compensation |
$3.00M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-30.34M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-242.72% |
|
-242.72% |
|
-73.09% |
|
-242.72% |
|
$5.89 |
|
$-9.56 |
|
$-9.93 |
|